TMS for Cervical Dystonia
Trial Summary
Will I have to stop taking my current medications?
The trial requires that you stop taking medications used for treating dystonia symptoms, such as anticholinergics, benzodiazepines, and muscle relaxants, at least one month before the study.
What data supports the effectiveness of the treatment fMRI-guided Individualized TMS for Cervical Dystonia?
Is transcranial magnetic stimulation (TMS) safe for humans?
How is the treatment fMRI-guided Individualized TMS unique for cervical dystonia?
This treatment is unique because it uses fMRI (functional magnetic resonance imaging) to guide the application of TMS (transcranial magnetic stimulation), allowing for personalized targeting of brain areas involved in cervical dystonia. This approach aims to modulate brain activity more precisely compared to standard TMS, potentially improving treatment outcomes by addressing individual differences in brain activation patterns.348910
What is the purpose of this trial?
This study aims to investigate the impact of accelerated transcranial magnetic stimulation (TMS) on brain function and behavior in patients with focal cervical dystonia. Previous research demonstrated that individualized TMS improved writing behavior in focal hand dystonia after one session. In this study, we aim to expand the application on TMS on focal cervical dystonia. The current study administers four TMS sessions in a day. The research involves 9 in-person visits. The effect of TMS will be assessed using functional MRI brain scans and behavioral measurements. The risk of TMS includes seizures; the potential risk of seizures from TMS is mitigated through careful screening, adhering to safety guidelines. The study's main benefit is enhancing dystonic behavior and deepening the understanding of brain changes caused by TMS in cervical dystonia, paving the way for further advancements in clinical therapy for this condition.
Research Team
Noreen Bukhari-Parlakturk, MD PhD
Principal Investigator
Duke Health
Eligibility Criteria
This trial is for individuals with conditions like isolated focal hand dystonia, general dystonia, or torticollis. Participants should be able to attend 10 in-person visits and undergo MRI scans and behavior analysis. The study excludes those at risk of seizures or who don't meet the safety guidelines for TMS.Inclusion Criteria
Exclusion Criteria
Timeline
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants receive accelerated TMS sessions, with four sessions administered in a single day during two in-person visits.
Assessment
Changes in brain function and behavior are evaluated using functional MRI and behavioral assays after each TMS session.
Follow-up
Participants are monitored for changes in neck angles and brain activity post-TMS and potentially post-DBS.
Treatment Details
Interventions
- fMRI-guided Individualized TMS
Find a Clinic Near You
Who Is Running the Clinical Trial?
Duke University
Lead Sponsor
American Academy of Neurology
Collaborator